Patents by Inventor Sadakazu Yokomori

Sadakazu Yokomori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5753673
    Abstract: Quinolinecarboxylic acid derivatives represented by the following formula: ##STR1## wherein C is hydroxymethyl, methoxy, ethoxy or morpholinyl, or pharmaceutically acceptable salts thereof exhibit a potent action for stimulating a serotonin 4 receptor. The compounds exhibit an action of enhancing the gastrointestinal motor function to improve the gastrointestinal conditions such as heartburn, anorexia, bowel pain, abdominal distension, etc., accompanied by chronic gastritis, diabetes mellitus or postoperative gastroparesis, and are thus effective for the treatment of gastro-esophagal reflux, intestinal pseudo-obstruction and constipation.
    Type: Grant
    Filed: January 18, 1996
    Date of Patent: May 19, 1998
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Yutaka Ohuchi, Masaji Suzuki, Hajime Asanuma, Sadakazu Yokomori, Katsuo Hatayama
  • Patent number: 5733917
    Abstract: Endo-(8-methyl-8-azabicyclo?3.2.1!oct-3-yl) 1-isopropyl-2(1H)-quinolone-3-carboxylate represented by Formula (I): ##STR1## or an acid addition salt thereof acts on a serotonin 4 receptor thereby to have a serotonin-like receptor stimulating activity, therefore has an action on activating gastrointestinal motor functions and thus is effective for the improvement of gastrointestinal conditions such as heartburn, anorexia, bowel pain or abdominal distension accompanied by chronic gastritis or postoperative gastroparesis, and further for the treatment of gastro-esophagal reflux, intestinal pseudo-obstruction or constipation.
    Type: Grant
    Filed: August 21, 1996
    Date of Patent: March 31, 1998
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Yutaka Ohuchi, Masaji Suzuki, Hajime Asanuma, Sadakazu Yokomori, Katsuo Hatayama, Yoshihiko Isobe, Haruko Kijima, Makoto Muramatsu
  • Patent number: 5571820
    Abstract: Endo-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1 -isopropyl-2(1H)-quinolone-3-carboxamide shown by formula (I): ##STR1## or an acid addition salt thereof exhibits a potent action for stimulating a serotonin 4 receptor and is effective for the treatment of diseases and for the improvement of conditions, caused by a reduced motility in the gastrointestinal tract.
    Type: Grant
    Filed: April 28, 1995
    Date of Patent: November 5, 1996
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Yutaka Ohuchi, Masaji Suzuki, Hajime Asanuma, Sadakazu Yokomori, Katsuo Hatayama, Yoshihiko Isobe, Chika Ito, Makoto Muramatsu
  • Patent number: 5347012
    Abstract: A naphthothiopyranone derivative represented by the formula: ##STR1## (wherein R.sup.1 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms) and an acid addition salt thereof have more excellent antagonist effect at serotonin 3 receptors than the prior art compounds and the effects based thereon, e.g. anti-vomiting effect, gastrointestinal movement regulating effect and anti-anxiety effect.
    Type: Grant
    Filed: December 11, 1992
    Date of Patent: September 13, 1994
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Tatsuhiko Sano, Keiko Saijo, Sadakazu Yokomori, Yoshimoto Nakashima, Katsuo Hatayama
  • Patent number: 5089654
    Abstract: Chalcone derivatives represented by the formula ##STR1## wherein R.sup.1 is a straight chain, branched chain or cyclic alkyl group having 4 to 15 carbon atoms or an alkenyl group having 3 to 15 carbon atoms, and occurs at the 2- or 4-position, R.sup.2 is a hydrogen atom, a straight or branched chain alkyl group having 1 to 3 carbon atoms, and X is a straight or branched chain alkylene group having 1 to 3 carbon atoms, are disclosed. These compounds have anti-ulcer effect, gastric mucosal protection effect and antisecretory effect.
    Type: Grant
    Filed: August 3, 1990
    Date of Patent: February 18, 1992
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Sadakazu Yokomori, Keiko Saijo, Tohru Matsunaga, Yoshimoto Nakashima, Katsuo Hatayama
  • Patent number: 4980474
    Abstract: An apovincaminic acid derivative represented by the formula ##STR1## wherein n is an integer of from 2 to 11, and a pharmaceutically acceptable salt thereof are disclosed. These compounds are useful for therapy of cerebrovascular injuries, peripheral vessel injuries, angina pectoris, hypertension and senile dementia.
    Type: Grant
    Filed: September 12, 1989
    Date of Patent: December 25, 1990
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Masatoshi Hayashi, Sadakazu Yokomori, Yoshimoto Nakashima, Katsuo Hatayama
  • Patent number: 4883876
    Abstract: Vincaminic acid derivatives represented by the formula ##STR1## wherein R.sup.1 is a hydrogen atom, an alkyl group having 1 to 8 carbon atoms or an alkoxyalkyl group having 2 to 6 carbon atoms, R.sup.2 is a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a halogenated alkyl group having 1 to 5 carbon atoms, a cycloalkyl group having 3 to 6 carbon atoms, an alkoxycarbonylallyl group having 3 to 8 carbon atoms, an alkenyl group having 2 to 4 carbon atoms, a phenyl group, a phenyl group substituted by alkoxy groups each having 1 or 2 carbon atoms or a thienyl group, A is a hydroxy group, B is a hydrogen atom, or A and B together form a valence bond, and the acid addition salts thereof are disclosed. These compound are useful as thereapeutic effect on cerebovascular injuries.
    Type: Grant
    Filed: September 2, 1988
    Date of Patent: November 28, 1989
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Shin-ichi Nakatsuka, Masatoshi Hayashi, Sadakazu Yokomori, Yoshimoto Nakashima, Katsuo Hatayama, Hiroaki Araki
  • Patent number: 4085135
    Abstract: Novel 2'-(carboxymethoxy)-chalcones of the formula ##STR1## wherein one or two of X.sup.1, X.sup.2 and X.sup.3 are 3-methyl-2-butenyloxy and the other or others are hydrogen, possess excellent antigastric and anti-duodenal ulcer activities, together with a high absorptive ratio in the living body and low acute and chronic toxicity.
    Type: Grant
    Filed: February 11, 1977
    Date of Patent: April 18, 1978
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Kazuaki Kyogoku, Katsuo Hatayama, Sadakazu Yokomori, Jiro Sawada, Ichiro Tanaka